How does TAFINLAR + MEKINIST treat NSCLC?
TAFINLAR and MEKINIST are prescription medicines that can be used in combination to treat a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic NSCLC), and that has a certain type of abnormal “BRAF V600E” gene. TAFINLAR, in combination with MEKINIST, is not for use in treating people with wild-type BRAF NSCLC.
Could TAFINLAR + MEKINIST be right for you?
Your health care provider will perform a biomarker test to make sure that TAFINLAR, in combination with MEKINIST, is right for you.
It is not known if TAFINLAR with MEKINIST is safe and effective in children younger than 6 years of age.
TAFINLAR + MEKINIST is a proven choice for patients with BRAF V600E metastatic NSCLC.